US 9732095
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted A61PA61P1/02A61P1/04
Quick answer
US patent 9732095 (Bicyclic heterocyclyl derivatives as IRAK4 inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 77
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18